This story has been updated to clarify the description of analytical validation data presented on the virtual ASCO poster.
NEW YORK – Avida Biomed, a startup founded by genomics industry veterans with clinical experience, is developing a methylation sequencing-based, targeted panel for use in diagnosing cancer.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.